Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

709 evidence items · page 18 / 29

29 %Symptomatic infections accounted for 29% (644/2246) of all malaria-positive individuals.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

30 %Among HIV-infected adults interviewed, 30% had no stable partnership.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations

13.5 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 13.5% for those who did not identify HPV as cervical cancer aetiology and 35.1% for those who did identify HPV as cervical cancer aetiology in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobserved 2025HAL · Unilimdocument of 69 observations

3.4 %Among the 313 HIV antibodies carriers in Ivory Coast from January to December 1987, 3.4% had a double seropositivity to HIV1 and HIV2.

Côte d'IvoireHIV1 and HIV2observed 1987published 1989PubMedOpenAlexdocument of 10 observations

8.9 %Among adolescent girls living with HIV in Côte d'Ivoire, 8.9% reported parents' refusal as a barrier to HPV vaccination.

Côte d'Ivoireinfection à HPV · VIH/sidaobserved 2024–2025HAL · Unilimdocument of 69 observations

1 %The Cameroun haplotype was detected in 1% of the samples.

Côte d'Ivoirehemoglobin disordersHAL · Unilimdocument of 23 observations

3 %The prevalence of sickle cell disease was 3% in the population analyzed.

Côte d'IvoiredrépanocytoseHAL · Unilimdocument of 23 observations

0.3 per_100_person_weeksThe mean malaria incidence was 0.30 case per 100 person-weeks.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

36 %Among hospitalized HIV-positive adults in West Africa who died, tuberculosis was the most frequent fatal disease, occurring in 36% of deaths.

Côte d'Ivoiretuberculose · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

1.24 %Mixed infection of Plasmodium falciparum and Plasmodium malariae accounted for 1.24% of identified Plasmodium species among 2246 positive blood smears.

Côte d'IvoirePlasmodium falciparum + Plasmodium malariaeHAL · Unilimdocument of 122 observations

755 participantsAt baseline, 755 participants initiated antiretroviral therapy in the Temprano randomized trial in Abidjan.

Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations

43.8 %Detectable HCV RNA was identified in 43.8% of anti-HCV positive HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

33.7 %The estimated prevalence of HIV infection among female sex workers in Abidjan, Côte d'Ivoire was 33.7%.

Côte d'IvoireVIH/sidaobserved 2013published 2015BMC oral healtheurope_pmcdocument of 7 observations

54 %In Côte d'Ivoire, the overall prevalence of high-risk HPV in women living with HIV of childbearing age was estimated to be 54%.

Côte d'Ivoirehigh-risk HPVHAL · Unilimdocument of 69 observations

94.7 %Infection prevalence was 94.7% in Survey 2 among 860 participants.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

1.66 hazard_ratioPatients aged ≥60 years had an increased risk of death in the first 36 months on ART with an adjusted hazard ratio of 1.66.

Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations

23.4 %Plasmodium falciparum was detected in 23.4% of afebrile people in Côte d'Ivoire.

Côte d'Ivoirepaludismepublished 2021Travel medicine and infectious diseasePubMeddocument of 25 observations

34.2 %Tuberculosis accounted for 34.2% of AIDS-defining reasons for hospitalization.

Côte d'Ivoiretuberculose · VIH/sidapublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations

No external and visible congenital malformation was observed in HIV-infected women exposed to efavirenz during pregnancy.

Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

8.6 per_100_person-yearsHIV incidence among regular female blood donors in Abidjan decreased from 8.6 per 100 person-years in 1992–1994 to 0.11 per 100 person-years in 2010–2012.

Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations

5.5 %Comorbidities were present in 5.5% of afebrile people in Côte d'Ivoire.

Côte d'Ivoirecomorbiditiespublished 2021Travel medicine and infectious diseasePubMeddocument of 25 observations

4 %HCV prevalence was 4.0% among HIV-1&2 dually reactive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

19.1 %The prevalence of non-obstructive carotid plaques was 19.1%.

Côte d'Ivoirenon-obstructive carotid plaquesobserved 2015published 2021Southern African journal of infectious diseaseseurope_pmcdocument of 9 observationsDOI 10.4102/sajid.v36i1.187

1 %1% of 1,234 new samples from the Ivory Coast, Kenya, South Africa, Thailand, and the United States were identified as elite neutralizers.

Afrique du Sud · Côte d'Ivoire · KenyaVIH/sidapublished 2009Journal of virologyeurope_pmcdocument of 2 observationsDOI 10.1128/jvi.00110-09

64 %Among HIV-infected adults interviewed, 64% could not be given any recommendation regarding early initiation of antiretroviral treatment (ART) due to either no stable partnership (30%) or being in a stable partnership with an unaware partner status (34%).

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.